To investigate whether transport of L-arginine into neurons plays an integral role in the metabolism of the novel neuromodulator nitric oxide, the uptake of L-[3H]arginine was characterized in cultured neurons of mouse cerebellum and cerebral cortex (neocortex). The transport of L-[3H]arginine was saturable and monophasic into both types of neurons with an apparent Km of 100 microM and Vmax of 2.6 nmol/min/mg of protein. The transport process was stereospecific, and the pattern of inhibition by basic L-amino acids was consistent with a "y+" transport system. The potencies with regard to inhibition of L-arginine uptake of the two inhibitors of nitric oxide synthase, NG-monomethyl-L-arginine and NG-amino-L-arginine (IC50 values of 120 and 65 microM, respectively), suggest that these nitric oxide synthase inhibitors may also reduce formation of nitric oxide and cyclic GMP via a block of arginine uptake. Overall, these data indicate that uptake of L-arginine could regulate its intracellular concentration and, consequently, its availability for synthesis of nitric oxide.
No takes yet. Share an insight, caveat, or question.
Westergaard et al. (1993) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: